Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: The randomized Femoral Artery In-Stent Restenosis (FAIR) trial

Circulation

Volumn 132, Issue 23, 2015, Pages 2230-2236

  Krankenberg, Hans ^a   Tübler, Thilo ^b   Ingwersen, Maja ^a   Schlüter, Michael ^c   Scheinert, Dierk ^d   Blessing, Erwin ^e   Sixt, Sebastian ^f   Kieback, Arne ^g   Beschorner, Ulrich ^h   Zeller, Thomas ^h  

^a Cardiovascular Center Bad Bevensen   (Germany)

^b Medtronic   (Germany)

^c Asklepios Proresearch   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Department of Internal Medicine   (Germany)

^f UNIVERSITY HEART CENTER HAMBURG   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

angioplasty; angioplasty, balloon; coronary restenosis; peripheral arterial disease; randomized controlled trial

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DRUG COATED BALLOON ANGIOPLASTY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARD BALLOON ANGIOPLASTY; STENT THROMBOSIS; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY IN STENT RESTENOSIS; TREATMENT OUTCOME; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; MIDDLE AGED; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STENT;

PACLITAXEL;

AGED; ANGIOPLASTY, BALLOON; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; STENTS;

EID: 84949425560     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017364     Document Type: Article

References (22)

1. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T, ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011 32 2851 906
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 45 suppl S S5 S67. doi: 10.1016/j.jvs.2006.12.037.
3. Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P, Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg 2011 54 1042 1050. doi: 10.1016/j.jvs.2011.03.272.
4. Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Muramatsu T, Inoue N, Nanto S, Uematsu M, Long-Term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther 2011 18 753 761. doi: 10.1583/11-3581.1.
5. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, RESILIENT Investigators Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010 3 267 276. doi: 10.1161/CIRCINTERVENTIONS.109.903468.
6. Krankenberg H, Tübler T, Sixt S, Fischer M, Schmiedel R, Schulte KL, Balzer JO, Kieback A, Fiehn E, Wittenberg G, Ali T, Tiefenbacher C, Jahnke T, Steinkamp HJ, Wegscheider K, Treszl A, Ingwersen M, Zeller T, German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization. J Endovasc Ther 2014 21 463 471. doi: 10.1583/13-4625R.1.
7. Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR Jr, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K, SUPERB Trial Investigators Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial [published online ahead of print May 8, 2015]. Circ Cardiovasc Interv. doi: 10.1161/CIRCINTERVENTIONS.113.000937. http://circinterventions.ahajournals.org/content/8/5/e000937.long. Accessed May 21, 2015.
8. Werner M, Paetzold A, Banning-Eichenseer U, Scheinert S, Piorkowski M, Ulrich M, Bausback Y, Bräunlich S, Schmidt A, Scheinert D, Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention 2014 10 861 868. doi: 10.4244/EIJV10I7A147.
9. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS, Zilver PTX Investigators Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011 4 495 504. doi: 10.1161/CIRCINTERVENTIONS.111.962324.
10. Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M, Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery. JACC Cardiovasc Interv 2014 7 792 798. doi: 10.1016/j.jcin.2014.01.168.
11. Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, Fusaro M, Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 2012 5 582 589. doi: 10.1161/CIRCINTERVENTIONS.112.969972.
12. Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Esposito G, Trimarco B, Rubino P, Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv 2014 7 411 415. doi: 10.1016/j.jcin.2013.11.020.
13. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, Sorropago G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Biamino G, Rubino P, Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012 60 1739 1742. doi: 10.1016/j.jacc.2012.07.033.
14. Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L, Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther 2014 21 1 8. doi: 10.1583/13-4420R.1.
15. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN, Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997 26 517 538
16. Ranke C, Creutzig A, Alexander K, Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992 18 433 440
17. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M, Cejna M, Minar E, Schillinger M, Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008 248 297 302. doi: 10.1148/radiol.2481071159.
18. Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A, Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv 2013 6 274 281. doi: 10.1016/j.jcin.2012.12.118.
19. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G, Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013 20 805 814. doi: 10.1583/13-4308MR.1.
20. Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, Schroë H, Lansink W, Scheinert D, Schmidt A, Zeller T, Beschorner U, Noory E, Torsello G, Austermann M, Peeters P, Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial. J Endovasc Ther 2015 22 1 10. doi: 10.1177/1526602814564385.
21. Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon-Hernandez PJ, Stark MA, Walker C, EXCITE ISR Investigators Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv 2015 8 pt A 92 101. doi: 10.1016/j.jcin.2014.09.009.
22. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, Yokoi H, Nanto S, Nobuyoshi M, Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012 59 16 23. doi: 10.1016/j.jacc.2011.09.036.